Postpartum pain. Postpartum care and examination
Conditions
Interventions
Intervention 1: Intervention group: Mefenamic acid at the dose of 500 mg (two 250mg capsules) plus Zintoma, Produced by Gol Dara Company, at the dose of 500 mg (two 250mg capsules) are prescribed two
Treatment - Drugs
Intervention group: Mefenamic acid at the dose of 500 mg (two 250mg capsules) plus Zintoma, Produced by Gol Dara Company, at the dose of 500 mg (two 250mg capsules) are prescribed two hours after deli
Control group: Mefenamic acid at the dose of 500 mg (two 250mg capsules) plus placebo (containing Chickpea Flour Produced by Gol Daru similar to Zintoma in Dose and shape) , at the dose of 500 mg (two
Sponsors
Vice Chancellor for research of International Branch of Shahid Beheshti University of Medical Scien
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Iranian with reading and writing skills; Delivery by vaginal method; Pregnancy age of 38 weeks and more; The baby's weight more than 2500 grams; Having a living and normal baby; Mothers without previous cesarean or surgery history; lasting 2 hours after delivery; childbirth without the help of instrument (Vacuum and Forceps) or pressure on the uterus;absence of drug addiction; having no history of allergies to ginger and herbal medicine; mother with complains of after pain; absence of uses of medications and analgesia (epidural anesthesia, Spinal anesthesia, Entonox and pethidine)during labour; the mother is not affected by chronic disease, such as diabetes and hypertension; spontaneous existance of placenta and membrane. Exclusion Criteria: Maternal complications such as increased postpartum hemorrhage, fever and blood pressure over 140/90; requiring surgery and anesthetics.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Before the intervention, half,one and two hours after intervention, then every 8 hours. Method of measurement: Numerical Measurement Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of additional painkiller intake. Timepoint: 2 hours after delivery and then every 8 hours for 24 hours. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGiti Ozgoli
Shahid Beheshti University of Medical Sciences
Outcome results
None listed